Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant allergens in the US.

Jay E Slater1

  • 1Laboratory of Immunobiochemistry, Division of Bacterial Parasitic and Allergenic Products, Office of Vaccines Regulation and Research, Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, MD, USA.

Methods (San Diego, Calif.)
|February 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunizations Are Critical for Our Health: We Need to Act Now to Save Them.

The journal of allergy and clinical immunology. In practice·2026
Same author

Identifying immunodominant proteins in mouse urine.

The Journal of allergy and clinical immunology·2025
Same author

Cockroach immunotherapy modulates dominant T-cell responses independent of allergen extract content.

The Journal of allergy and clinical immunology·2025
Same author

Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop.

The Journal of allergy and clinical immunology·2025
Same author

Distinct proteomes and allergen profiles appear across the life-cycle stages of Alternaria alternata.

The Journal of allergy and clinical immunology·2024
Same author

Vitellin/Vitellogenin Is an Important Allergen in German Cockroach.

International archives of allergy and immunology·2024
Same journal

An accessible, absorbance-based plate reader assay to assess cumulative exposure of blood plasma & serum to thawed conditions.

Methods (San Diego, Calif.)·2026
Same journal

EC-isHCR: A rapid method for in situ hybridization chain reaction in diverse animal samples.

Methods (San Diego, Calif.)·2026
Same journal

Single-Molecule methods to investigate mechanisms of transcription by RNA polymerase of Mycobacterium tuberculosis.

Methods (San Diego, Calif.)·2026
Same journal

Detection and sequencing of Usutu virus during mosquito surveillance: Use of multiple assays and techniques for identification at low levels.

Methods (San Diego, Calif.)·2026
Same journal

Experimental validation of an AI-driven digital healthcare platform for oral health behavior and plaque assessment among vietnamese children.

Methods (San Diego, Calif.)·2026
Same journal

Zeta potential: An efficient and cost-effective alternative for investigating cell-surface interactions.

Methods (San Diego, Calif.)·2026
See all related articles

Recombinant allergens offer improved safety and efficacy for allergy diagnostics and treatments. Addressing biological and regulatory challenges is crucial for their clinical application.

Area of Science:

  • Biotechnology
  • Immunology
  • Allergenics

Background:

  • Recombinant allergens present an opportunity to enhance allergen immunodiagnostics and immunotherapy.
  • They can serve as valuable tools for standardizing natural allergens.

Purpose of the Study:

  • To discuss the biological and regulatory issues associated with the clinical translation of recombinant allergens.

Main Methods:

  • Literature review and discussion of current challenges in recombinant allergen development.

Main Results:

  • Recombinant allergens show potential for improved diagnostic and therapeutic applications.
  • Several biological and regulatory hurdles must be overcome for successful clinical implementation.

Related Experiment Videos

Conclusions:

  • Recombinant allergens hold promise for advancing allergy care.
  • Addressing specific biological and regulatory considerations is essential for moving these products from research to clinical practice.